Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Cancer Causes & Control
Erschienen in: Cancer Causes & Control 4/2010

01.04.2010 | Original paper

Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites

verfasst von: Jacqueline Chan, Karen Jaceldo-Siegl, Gary E. Fraser

Erschienen in: Cancer Causes & Control | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To develop algorithms predicting serum 25 hydroxyvitamin D [s25(OH)D] for a large epidemiological study whose subjects come from large geographic areas, are racially diverse and have a wide range in age, skin types, and month of blood sample collection. This will allow a regression calibration approach to determine s25(OH)D levels replacing the more costly method of collection and analysis of blood samples.

Study design and setting

Questionnaire data from a subsample of 236 non-Hispanic whites (whites) and 209 blacks from the widely dispersed Adventist Health Study-2 (n = 96,000) were used to develop prediction algorithms for races separately and combined. A single blood sample was collected from each subject, at different times throughout the year.

Results

Models with independent variables age, sex, BMI, skin type, UV season, erythemal zone, total dietary vitamin D intake, and sun exposure factor explained 22 and 31% of the variance of s25(OH)D levels in white and black populations, respectively (42% when combined). UV season and erythemal zone determined from measured UV radiation produced models with higher R 2 than season and latitude.

Conclusion

Combining races with a term for race and using variables with measured UV radiation capture the variance in s25(OH)D levels better than analyzing races separately.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080–1086
2.
Chen TC, Chimeh F, Lu Z et al (2007) Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460:213–217CrossRefPubMed
3.
Holick MF, MacLaughlin JA, Doppelt SH (1981) Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 211:590–593CrossRefPubMed
4.
Egan K, Signorello L, Munro H, Hargreaves M, Hollis B, Blot W (2008) Vitamin D insufficiency among African–Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control 19:527–535CrossRefPubMed
5.
Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459PubMedCrossRef
6.
Jacobs ET, Alberts DS, Foote JA et al (2008) Vitamin D insufficiency in southern Arizona. Am J Clin Nutr 87:608–613PubMed
7.
Johnson MA, Davey A, Park S, Hausman DB, Poon LW (2008) Age, race and season predict vitamin d status in African American and white octogenarians and centenarians. J Nutr Health Aging 12:690–695PubMed
8.
Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771–777CrossRefPubMed
9.
Nesby-O’Dell S, Scanlon KS, Cogswell ME et al (2008) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third national health and nutrition examination survey, 1988–1994. Am J Clin Nutr 76:187–192
10.
van der Meer IM, Boeke AJP, Lips P et al (2008) Fatty fish and supplements are the greatest modifiable contributors to the serum 25-hydroxyvitamin D concentration in a multiethnic population. Clin Endocrinol 68:466–472
11.
Bolland MJ, Chiu WW, Davidson JS et al (2008) The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency. N Z Med J 121:63–74PubMed
12.
13.
Jacques PF, Felson DT, Tucker KL et al (1997) Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 66:929–936PubMed
14.
MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536–1538CrossRefPubMed
15.
Need AG, Morris HA, Horowitz M, Nordin C (1993) Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 58:882–885PubMed
16.
Holick MF (2005) The vitamin D epidemic and its health consequences. J Nutr 135:2739–2748
17.
Lucas J, Bolland M, Grey A et al (2005) Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 16:1641–1648CrossRefPubMed
18.
McKinney K, Breitkopf CR, Berenson AB (2008) Association of race, body fat, and season with vitamin D status among young women: a cross-sectional study. Clin Endocrinol 69:535–541CrossRef
19.
Rock CL, Thornquist MD, Kristal AR et al (1999) Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra post-marketing surveillance study. J Nutr 129:855–864PubMed
20.
Clemens TL, Henderson SL, Adams JS, Holick MF (1982) Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 319:74–76CrossRef
21.
Gozdzik A, Barta JL, Wu H et al (2008) Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMC Public Health 8:336CrossRefPubMed
22.
Holick MF (1981) The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 77:51–58CrossRefPubMed
23.
Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF (1987) Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64:1165–1168CrossRefPubMed
24.
Hill TR, O’Brien MM, Lamberg-Allardt C et al (2006) Vitamin D status of 51–75 year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr 9:225–233CrossRefPubMed
25.
Hintzpeter B, Mensink GBM, Thierfelder W, Muller MJ, Scheidt-Nave C (2007) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079–1089CrossRefPubMed
26.
Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP (2006) Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 25:395–402PubMed
27.
Looker AC (2005) Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 90:635–640CrossRefPubMed
28.
Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE (2009) Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem 40:1174–1177CrossRef
29.
Andersen R, Molgaard C, Skovgaard LT et al (2005) Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59:533–541CrossRefPubMed
30.
Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sørensen OH (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 86:97–103CrossRef
31.
Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E (2004) Vitamin D status of middle-aged women at 65–71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 7:327–335PubMed
32.
Burgaz A, Akesson A, Oster A, Michaelsson K, Wolk A (2007) Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 86:1399–1404PubMed
33.
Hirani V, Mosdol A, Mishra G (2009) Predictors of 25-hydroxyvitamin D status among adults in two British national surveys. Br J Nutr 101:760–764CrossRefPubMed
34.
Lips P, van Ginkel FC, Jongen MJ et al (1987) Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr 46:1005–1010PubMed
35.
van Dam RM, Snijder MB, Dekker JM et al (2007) Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn study. Am J Clin Nutr 85:755–761PubMed
36.
McCarty CA (2008) Sunlight exposure assessment: can we accurately assess vitamin D exposure from sunlight questionnaires? Am J Clin Nutr 87:1097–1101
37.
Millen AE, Bodnar LM (2008) Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 87:1102–1105
38.
Hoeppe P, Oppenrieder A, Erianto C et al (2004) Visualization of UV exposure of the human body based on data from a scanning UV-measuring system. Int J Biometeorol 49:18–25CrossRefPubMed
39.
Webb AR, Weihs P, Blumthaler M (1999) Spectral UV radiance on vertical surfaces: a case study. Photochem Photobiol 69:464–470CrossRefPubMed
40.
41.
Butler TL, Fraser GE, Beeson WL et al (2008) Cohort profile: the adventist health study-2 (AHS-2). Int J Epidemiol 37:260–265CrossRefPubMed
42.
Jaceldo-Siegl K, Knutsen S, Sabate J et al. (2009) Validation of nutrient intake using a food-frequency questionnaire and repeated 24 h recalls in Black and White subjects of the Adventist Health Study-2 (AHS-2). Public Health Nutr (in press)
43.
Willett WC, Stampfer MJ (1998) Implications of total energy intake for epidemiologic analyses. In: Willett W (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, pp 273–301
44.
Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869–871CrossRefPubMed
45.
Wachtel TL, Berry CC, Wachtel EE, Frank HA (2000) The inter-rater reliability of estimating the size of burns from various burn area chart drawings. Burns 26:156–170CrossRefPubMed
46.
Diffey BL (1991) Solar ultraviolet radiation effects on biological systems. J Phys Medicine Biology 36:299–328CrossRef
47.
Webb AR, Engelsen O (2006) Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 82:1697–1703PubMed
48.
49.
Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (1993) Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91:2552–2555CrossRefPubMed
50.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693PubMed
51.
Young KA, Engelman CD, Langefeld CD et al (2009) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94:3306–3313CrossRefPubMed
52.
Malvy DJM, Guinot C, Preziosi P et al (2000) Relationship between vitamin D status and skin phototype in general adult population. Photochem Photobiol 71:466–469CrossRefPubMed
53.
Fears TR, Bird CC, Guerry DIV et al (2002) Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 62:3992–3996PubMed
54.
Lee-Taylor J, Madronich S (2007) Climatology of UV-A, UV-B, and erythemal radiation at the earth’s surface, 1979–2000. NCAR Technical Note TN-474-STR
55.
Al-Delaimy WK, Jansen EHJM, Peeters PHM et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers V11:370–382CrossRef
56.
Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502–1508PubMed
57.
Fraser GE (2003) A search for truth in dietary epidemiology. Am J Clin Nutr 78:521–525
58.
Bischoff-Ferrari HA, Dawson-Hughes B (2007) Where do we stand on vitamin D? Bone 41:S13–S19CrossRefPubMed
59.
Hollis BW (2008) Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 88:507–510
60.
Ovesen L, Brot C, Jakobsen J (2003) Food contents and biological activity of 25-hydroxyvitamin D:A vitamin D metabolite to be reckoned with? Ann Nutr Metab 47:107–113CrossRefPubMed
61.
Holden JM, Lemar LE, Exler J (2008) Vitamin D in foods: development of the US Department of Agriculture database. Am J Clin Nutr 87:1092–1096
62.
Dlugos DJ, Perrotta PL, Horn WG (1995) Effects of the submarine environment on renal-stone risk factors and vitamin D metabolism. Undersea Hyperb Med 22:145–152PubMed
63.
Holick MF (1989) Vitamin D: biosynthesis, metabolism, and mode of action. In: DeGroot LJ, Cahill GF Jr, Martini L et al (eds) Endocrinology. Grune and Stratton, New York, pp 902–926
64.
Kobayashi T, Okano T, Shida S et al (1983) Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol (Tokyo) 29:271–281
Metadaten
Titel
Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites
verfasst von
Jacqueline Chan
Karen Jaceldo-Siegl
Gary E. Fraser
Publikationsdatum
01.04.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 4/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9481-1

Weitere Artikel der Ausgabe 4/2010

Cancer Causes & Control 4/2010 Zur Ausgabe

Original paper

Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers

Original paper

Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study

Original paper

Moderate physical activity and breast cancer risk: the effect of menopausal status

Original paper

One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case–referent study

Original paper

Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study

Brief report

The impact of delayed blood centrifuging, choice of collection tube, and type of assay on 25-hydroxyvitamin D concentrations

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise